Jayex to sell its on-premises Acute (hospital) queue management business for £1.3M (3.1x
recurring earnings) to Canadian based medical technology company Vitalhub Inc with
completion expected end of April 2021
• Vitalhub to purchase all existing hospital contractsin the UK and Australia from Jayex, including
an Enlighten license to operate the services
• Transaction value of £1.3M (~$2.4M AUD) in cash and Vitalhub shares + additional earn out
capacity of up to £1.0M (~$1.8M AUD)
• Jayex retains all IP and ownership of the Enlighten technology stack
• Divestment enables Jayex to focus on core and higher-margin NHS GP (Primary Care) and
Community markets and increase services offered through its SaaS based Connect platform
• Funds released for the development of NZ based cannabis subsidiary
Now were funded for development of the Medical Marijuana... No cash raise needed this is sounding better by the minute
- Forums
- ASX - By Stock
- Ann: Jayex divests Acute (hospital) queue management business
Jayex to sell its on-premises Acute (hospital) queue management...
- There are more pages in this discussion • 17 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add JTL (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $281K |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
21 | 75674084 | 0.1¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.2¢ | 1285222 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
21 | 75674084 | 0.001 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.002 | 1285222 | 3 |
0.003 | 1084302 | 3 |
0.004 | 673501 | 2 |
0.007 | 500000 | 1 |
0.010 | 4140000 | 1 |
Last trade - 16.12pm 07/06/2024 (20 minute delay) ? |
Featured News
JTL (ASX) Chart |
Day chart unavailable